Cryptosporidium is a major cause of moderate to severe diarrhea in humans worldwide, second only to rotavirus. Due to the wide host range and environmental persistence of this parasite, cryptosporidiosis can be zoonotic and associated with foodborne and waterborne outbreaks. Currently, 31 species are recognized as valid and of these, Cryptosporidium hominis and Cryptosporidium parvum are responsible for the majority of infections in humans. The immune status of the host, both innate and adaptive immunity, has a major impact on the severity of the disease and its prognosis. Immunocompetent individuals
moderate clinical efficacy in malnourished children and immunocompetent people, and none in immunocompromosed individuals like people with HIV (38, 39) .
Because oocysts of Cryptosporidium species from humans and animals are ubiquitous in the environment, cryptosporidiosis can be acquired through multiple routes (reviewed by Robertson et al. 40) . Transmission of oocysts is by the faecal-oral route, either directly or indirectly. For humans, direct transmission can be from person to person primarily due to poor hygiene among household members and attendees in day-care centers, aged care facilities and other institutions, or from animals to persons such as farm-workers and pet owners. Most indirect transmission is from contaminated drinking or recreational water.
Contaminated food can also be a source of transmission and contamination can occur at every step throughout the food preparation process, from farm to table (41, 42) . Findings from
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animal models, human case reports, and a few epidemiological studies suggest that Cryptosporidium may also be transmitted via inhalation of aerosolized droplets or by contact with fomites contaminated by coughing (see 43) .
The "One Health" approach to tackle zoonotic diseases defined as "One Medicine" by Schwabe (1984) , is a worldwide strategy to improve health and well-being through the mitigation and prevention of disease risks that originate at the interface between humans, animals and their various environments (44) . This review focuses on a One Health approach to prophylactic prevention of cryptosporidiosis including improved detection, diagnosis and treatment, the importance of understanding zoonotic transmission, better environmental and risk management and the prospect of an effective anti-cryptosporidial vaccine.
DETECTION, DIAGNOSIS AND TREATMENT
Cryptosporidium presents many challenges for detection and diagnosis. The use of different diagnostic methods and the inconsistent application of typing techniques can make direct comparisons difficult or even impossible between clinical, veterinary and environmental testing or between different regions or countries (45) . Detection of Cryptosporidium in clinical pathology laboratories is still based mainly on microscopic detection via stains and/or fluorescent antibodies (IFA) and other antigenic detection methods. Although microscopy needs relatively simple instruments and cheap consumables, it is labour intensive, requires a skilled operator and lacks sensitivity and specificity (45) . Morphological characters for identifying Cryptosporidium are few (46, 47) and differential staining techniques are usually required due to the fact that oocysts are similar in size and shape to yeasts, fecal components and other debris (47, 48) . Acid fast (AF) modified Ziehl-Neelsen staining is one of the most common differential staining techniques (45, 48) . However, the detection limits of
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conventional microscopy for Cryptosporidium have been reported to be as low as 50, 000 to 500, 000 oocysts per gram of human faeces (49) , resulting in low levels of infection or sporadic shedding possibly going unnoticed when conventional methods of detection are used. Sporadic sheding is such that studies have shown that three separate faecal samples should be examined for immunocompetent patients and two samples for AIDS patients for confident diagnosis of cryptosporidial infections using acid-fast staining (50) . IFA stains offer superior sensitivity; in some studies, about 97% sensitivity compared with only about 75% sensitivity for acid-fast staining (51) . However, IFA is more expensive than acid-fast staining and requires a fluorescence microscope and trained staff (51) . This is particularly problematic in resource-poor areas where cryptosporidiosis is a major health problem. A recent study proposed the use of phase contrast microscopy (PCM) as a specific and inexpensive method for detection of Cryptosporidium, however this method still lacks sensitivity (52) .
Other antigen detection formats such as enzyme linked immunosorbent assays (ELISA's), enzyme immunoassays (EIA's) and immunochromatographic (dipstick) assay for Cryptosporidium are also commercially available and have the advantage of reducing assay times and being amenable to automation. However, diagnostic sensitivities are variable (70% to 100%) (51, (53) (54) (55) ; some rapid tests have reduced specificity and sensitivity for species other than C. parvum or C. hominis (56, 57) and confirmation of positive reactions is needed (55) . Biosensor chips, that detect and quantitate C. parvum in real-time via anti-C. parvum IgM binding have also been developed (58, 59) , however detection limits are relatively high (100 or more oocysts) and they have yet to be fully evaluated on water or faecal samples.
Another major limitation of both conventional microscopy and antigen detection methods is that they cannot identify to species or subtype level, which is essential for understanding transmission dynamics and outbreaks, in particular for zoonotic species.
This article is protected by copyright. All rights reserved. New drug targets for Cryptosporidium are urgently needed, as the only FDA-approved drug, nitazozanide, does not provide benefit for malnourished children and immunocompromised patients with cryptosporidiosis. However, Cryptosporidium has completely lost the plastid-derived apicoplast present in many other apicomplexans, and the remnant mitochondrion lacks the citrate cycle and cytochrome-based respiratory chain (68) . Therefore, many classic drug targets are unavailable in Cryptosporidium. Progress in developing anti-cryptosporidial drugs has also been affected by the inability to generate large numbers of Cryptosporidium oocysts in vitro and an inability to genetically manipulate the organism (69, 70) . The recent development of a hollow fiber in vitro culture system to generate large numbers of oocysts (up to 10 8 oocysts per day) (71) and advances in
genetically engineering Cryptosporidium (72), will transform the development of novel therapeutics.
To date, the best studied drug target is the bacterial derived inosine 5' -monophosphate dehydrogenase (IMPDH) gene, as Cryptosporidium does not contain guanine salvage enzymes and is totally dependant on this enzyme to convert adenosine salvaged from the host into guanine nucleotides (69, (74) (75) (76) . This coupled with the parasite's high metabolic demand for nucleotides due to the complicated lifecycle of this parasite make IMPDH an important drug target (77) (78) (79) (80) (81) (82) (83) (84) (85) .
Other drug targets include long chain fatty acyl-coenzyme A synthetases (LC-ACS) which are essential in fatty acid metabolism (68) and a recent study reported good efficacy of the ACS inhibitor triacsin C against cryptosporidial infection in mice (86) . A parasite cysteine protease inhibitor was also effective in vitro and in an animal model (87) . Other .
ZOONOTIC CRYPTOSPORIDIUM SPECIES
Due to the morphological similarity of Cryptosporidium oocysts from different host species, initial findings of Cryptosporidium infections in both domestic and wild animals were assumed to be due to C. parvum leading to an overestimation of the potential role of animals as reservoirs of human disease (92) . However, with the assistance of advanced molecular techniques, many of these species in wildlife particularly were identified as hostadapted genotypes (6, 10) . unpublished) and in fish (103) . Cryptosporidium parvum is primarily a parasite of artiodactyls and humans (4) but has also been frequently reported in wildlife, including various rodents, bovids, camelids, equids, canids, non-human primates and marine mammals (see 10) and in fish (103) (104) (105) (106) . Cryptosporidium meleagridis, although primarily a bird parasite, is the third most prevalent species infecting humans (4, 6, 93) and in some studies, C. meleagridis prevalence is similar to that of C. parvum (107, 108) . Cryptosporidium cuniculus (previously known as rabbit genotype) was responsible for a drinking-water
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associated outbreak of cryptosporidiosis in the UK (109-111) and has also been identified in many sporadic human cases of cryptosporidiosis (112) (113) (114) (115) . It is also the third most commonly identified Cryptosporidium species in patients with diarrhoea in the UK (112) .
Human infections with C. canis and C. felis have been reported mainly in studies conducted in children in developing countries (6) where they are responsible for as much as 3.3 and 4.4%, respectively, of overall cryptosporidiosis cases (116) . Cryptosporidium muris is also considered a zoonotic species as there have been numerous reports of C. muris in humans and one report in human sewage (117) (118) (119) (120) (121) (122) (123) (124) (125) (126) (127) (128) (129) . In a recent human infectivity study, C. muris was examined in six healthy adults (130) . Volunteers were challenged with 10 5 C. muris oocysts and monitored for 6 weeks for infection and/or illness. All six patients became infected. Only two of the infected volunteers had a diarrheal illness (a 33% illness attack rate). Three other volunteers passed an occasional unformed stool or typically had a single soft stool per day without any accompanying gastrointestinal symptoms (130) . Like C. muris, C. andersoni is also a gastric parasite and primarily infects the abomasum of cattle and to a lesser extent, sheep and goats (6, 93) . It is occasionally detected in humans (cf. 10). Two studies in China by the same research group have reported that C. andersoni was the most prevalent
Cryptosporidium species detected in humans (131) (132) . However, further research is required to better understand the zoonotic importance of C. andersoni.
Cryptosporidium ubiquitum is of public health concern because of its wide geographic distribution and broad host range (133) . It has been frequently reported from drinking source water and wastewater in various geographic locations, and is considered an emerging zoonotic pathogen as it has been identified in many human cases of cryptosporidiosis (133) .
Subtyping at the gp60 locus has suggested that sheep and wild rodents are a key source of C.
ubiquitum transmission to humans, through either direct human contact with infected animals or by contamination of drinking source water (133) . It is thought that human encroachment
into wildlife territories has been responsible for the emergence of C. ubiquitum and other genotypes like chipmonk genotype I and to a lesser extent, skunk and mink genotypes in human populations (133) (134) (135) (136) (137) (138) (139) (140) (141) (142) (143) . This highlights the importance of extensive molecular epidemiological studies of wildlife to better understand the public health risks.
RISK MANAGEMENT
A key part of a One Health approach to Cryptosporidium prophylaxis is a better understanding of environmental, epidemiological and aetiological factors associated with cryptosporidial infections to enable more targeted risk management. The far-reaching One
Health strategy aims at integrating multidisciplinary knowledge and evidence, and at coordinating the intervations, in order to create a global synergism catering for all aspects of health-care for humans, animals and the environment (the One Health Triad).
Under an environmental perspective, the prophylaxis of waterborne cryptosporidiosis must consider optimal management (or design) of source, recycled-and recreational-waters.
Protection of source water and swimming pools is a key element of Cryptosporidium prevention as contamination of drinking water and swimming pools is a major mode of transmission (see ref 33, 144, 145) and is often achieved by restricting the access to catchments and water bodies, while swimming pools are designed and monitored according to construction standards and guidelines. Infection prevention and management however, can only be achieved through a deep understanding of the routes of transmission, sources of contamination (human and animal), disease prevalence in the population, and the risk factors in the final host.
The link between Cryptosporidium in drinking water and sporadic infections is well documented (33, 144, 145) , however, the association between drinking water contamination and endemic cryptosporidiosis is not well established. For example, some studies reporting
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drinking unsafe water as a risk factor for endemic cryptosporidial infection (146, 147) and others report no association (148) (149) (150) . Seasonal patterns are also thought to be associated with an increased transmission risk (151, 152) , such as when recreational waters are more heavily utilised.
High precipitation events favor the transfer and survival of oocysts in surface waters and/or groundwater (153, 154) . This may result in contamination of source water and increased risk of cryptosporidiosis depending on the source of contamination (154 
This article is protected by copyright. All rights reserved. It has been shown that an important host risk factor includes HIV status.
Cryptosporidium is an important pathogen regardless of HIV-prevalence (16), however HIVpositive children are between 3 and 18 times more likely to have Cryptosporidium than those who were HIV-negative (166) (167) (168) . With the widespread availability of antiretroviral therapy, particularly in industrialised countries, the incidence of cryptosporidiosis has decreased among people living with AIDS (169). However, the increasing number of transplant recipients and those receiving immunosuppressive drugs may contribute significantly to the burden in the future (170, 171) . Malnutrition is also a risk factor for both diarrhea and prolonged diarrhea caused by Cryptosporidium, with significantly higher rates of infection in malnourished children controlling for HIV status (172) (173) (174) (175) . An unknown number of
individuals experience asymptomatic Cryptosporidium infection (176) . This clinically silent infection may remain undetected and untreated and therefore may contribute not only to parasite transmission but also to malnutrition and the associated clinical sequalae. Breastfeeding may provide some protection, as a recent study of Bangladeshi infants reported that protection from Cryptosporidium infection was associated with high anti-Cryptosporidium
IgA in breast milk (177) . 
This article is protected by copyright. All rights reserved. The mechanism by which MBL controls Cryptosporidium infection and protects children from it is still not clearly understood.
Adaptive immunity creates immunological memory after an initial response to
Cryptosporidium and leads to an enhanced response to subsequent encounters with
Cryptosporidium. For example, antibodies to the parasite antigen gp15 were associated with protection against reinfection (208) . The adaptive immune response to Cryptosporidium is characterized as a T-helper 1 (Th1) response (189) and the importance of the adaptive
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immune response during Cryptosporidium infection is highlighted by the susceptibility of AIDS patients to cryptosporidiosis, as well as the resolution of infection observed following CD4+ T lymphocyte cell reconstitution in patients given antiretroviral therapy (185, 209) .
Low absolute CD4+ T cell counts in patients with HIV/AIDS were thought to be responsible for persistent and severe cryptosporidiosis, however research with Simian immunodeficiency virus (SIV)-infected macaques reported that persistent cryptosporidiosis was more dependant on SIV load and profound viral damage to gut lymphoid tissue and rapid depletion of mucosal CD4+ T cells during the acute phase of viral infection, than on declining circulating CD4+ T cell levels during chronic SIV infection (210) . This suggests that depletion of local CD4+ T cells may be more predictive of disease severity than absolute CD4+ T cell numbers.
The importance of other T cells such as CD8+ have not been extensively studied but do appear to play a role (179) . The role of humoral immunity in protection from cryptosporidiosis is not well understood and no clear surrogate marker of protective immunity exists (reviewed in 46 and 179) .
The ideal Cryptosporidium vaccine should provide rapid life-long immunity in all vaccinated individuals, be broadly protective against the most common species and subtypes of Cryptosporidium, prevent disease transmission, and be readily accessible, stable, and cheap (178, 179) . Ensuring cross-reaction against the most common species infecting humans however will be difficult, as more than 20 Cryptosporidium species and genotypes can infect humans as discussed above. For example, a recent study showed that infection of gnotobiotic pigs with C. hominis resulted in complete protection against subsequent infection with C.
hominis, but incomplete protection against infection with C. parvum (211) , therefore multiple species will need to be targeted to provide sufficient cross-protection. In addition, as children, malnourished and immunocompromised individuals are the most important vaccine targets, they may not be able to develop a strong and sustained immune-mediated protection in
response to vaccination. Indeed, malnutrition has been cited as an important factor underlying limited efficacy of vaccines (212) . It is therefore likely that adjuvants such as TLR ligands (213) , will be required to enhance the immune-response in target populations (193, 196) .
Several antigens, aimed at raising immunoglobulin G antibodies, are being developed as vaccine candidates (178) . Some of the best studied are gp15 (214) (215) (216) (217) (218) (219) , cp15 (220) (221) (222) (223) (224) (225) and cp23 (223, 226, 227) . The gp15 antigen is derived from the glycoprotein gp60, which is cleaved by a parasite serine proteinase into two surface proteins -gp15 and gp40, both of which play an essential role in parasite motility and attachment to and invasion of host epithelial cells (228) , and can stimulate interferon γ production by peripheral blood mononuclear cells of those previously infected (214) , The gp15 antigen is relatively conserved between C. parvum and C. hominis, and studies in Bangladesh indicated that there is significant cross-reactivity between them and that antibodies to gp15 were associated with shorter duration of illness (217) . Similarly, in a study in Kenya, AIDS patients without diarrhea had significantly higher serum IgG levels to gp15 than those with diarrhea (229).
cp15 is an immunodominant protein present on the oocyst surface and is associated with internal structures and bears no apparent similarity to gp15 (228) . cp23 is an immunodominant protein, geographically conserved among C. parvum
isolates, is present in both the sporozoite and merozoite stages (178) , and antibodies to it are frequently detected following Cryptosporidium infection (231, 229) . Serum antibodies to
This article is protected by copyright. All rights reserved. Cryptosporidium infection in early infancy is scarce, and as a result, the burden of cryptosporidiosis is under-reported and under-estimated, which reinforces ineffective clinical and public health management of Cryptosporidium. Rapid, cost-effective and reliable diagnostic tests therefore need to be developed for non-industrialised countries to improve
detection, reporting and interpretation of results in the setting of multiple infections. With the recent improvements in cell culture and genetic manipulation, identification of novel or repurposed therapeutics should be radically transformed. Vaccines have the potential to reduce the significant burden of disease, but the extent and types of immunity necessary, and the methods by which to administer and induce protective immunity need further study.
